LEAD MODEL 302
Report
- Report Number
- 1644487-2011-01798
- Event Type
- Malfunction
- Date Received
- August 8, 2011
- Date of Event
- July 1, 2011
- Report Date
- July 11, 2011
- Manufacturer
- CYBERONICS, INC.
- Product Code
- MUZ
- PMA / PMN Number
- P970003
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- TX, US
- Reporter Occupation
- NOT APPLICABLE
Narratives
DEVICE MANUFACTURING RECORDS WERE REVIEWED. REVIEW OF MANUFACTURING RECORDS CONFIRMED THAT THE LEAD PASSED ALL FUNCTIONAL TESTS PRIOR TO DISTRIBUTION.
IT WAS REPORTED THAT THE PT HAD A PROBLEM WITH HER LEAD AND NEEDED REPLACEMENT. ATTEMPTS FOR ADD'L INFO HAVE BEEN UNSUCCESSFUL TO DATE.
ON (B)(4) 2013 IT WAS REPORTED THAT THE PATIENT HAD A CONSULT WITH THE SURGEON AND THAT HIGH IMPEDANCE WAS OBSERVED. NO FURTHER INFORMATION WAS PROVIDED. DEVICE MANUFACTURING RECORDS WERE REVIEWED. REVIEW OF MANUFACTURING RECORDS CONFIRMED THAT THE LEAD PASSED ALL FUNCTIONAL TESTS PRIOR TO DISTRIBUTION. ALTHOUGH SURGERY IS LIKELY, IT HAS NOT OCCURRED TO DATE.
ON (B)(6) 2013 IT WAS REPORTED THAT THE VNS PATIENT HAS BEEN HAVING PROBLEMS WITH HER LEAD ABOUT 1-1.5 YEARS AGO. THE PATIENT WAS QUESTIONING HAVING IT REMOVED. DEVICE MANUFACTURING RECORDS WERE REVIEWED. REVIEW OF MANUFACTURING RECORDS CONFIRMED THAT THE LEAD PASSED ALL FUNCTIONAL TESTS PRIOR TO DISTRIBUTION.
ADDITIONAL INFORMATION WAS RECEIVED THAT THERE WAS NO MENTION TO THE PHYSICIAN THAT THE PATIENT¿S GENERATOR WAS TURNED OFF AFTER THE HIGH IMPEDANCE WAS SEEN. NO X-RAYS WERE TAKEN OR PLANNED AND THERE WAS NOT MENTION TO THE PHYSICIAN OF ANY MANIPULATION OR TRAUMA.
IT WAS REPORTED THAT THE PATIENT UNDERWENT GENERATOR AND LEAD REPLACEMENT ON (B)(6) 2014. THE EXPLANTING FACILITY WILL NOT RETURN EXPLANTED DEVICES FOR ANALYSIS WITHOUT A SUBPOENA; THEREFORE, NO ANALYSIS CAN BE PERFORMED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | LEAD MODEL 302 | MUZ | CYBERONICS, INC. | 302-20 | 1330 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 56 YR |